Search
for
Sort by
Research 781–810 of 1000+
- Diagnosis of hyperandrogenism: clinical criteria
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- How should postmenopausal androgen excess be evaluated?
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Emerging treatments in alopecia
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Idiopathic Hirsutism*
- Combined hormonal contraception and venous thromboembolism
- Mitoxantrone
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Androgens and Antiandrogens
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Endocrine evaluation of hirsutism
- Dormancy in the stem cell niche
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women